Overview

Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The investigators are studying ways to improve pain control after surgery. One way to decrease pain is to inject incisions with a numbing medicine (local anesthetic) while in the operating room. There is an FDA approved extended-release version of a commonly used local anesthetic (bupivacaine) that can last for 4 days instead of 6 hours. The investigators are studying whether using the extended-release medication (Exparel) will give better pain relief after laparoscopic and robotic-assisted hysterectomies.
Phase:
Phase 4
Details
Lead Sponsor:
AdventHealth
Florida Hospital
Treatments:
Bupivacaine